Dr. Theresa Werner, MD
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Ovarian Cancer
Studies Adenocarcinoma
11 reported clinical trials
20 drugs studied
Area of expertise
1Ovarian Cancer
Stage IV
Stage III
Stage II
2Adenocarcinoma
Stage III
Stage IV
Stage II
Affiliated Hospitals
Clinical Trials Theresa Werner, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
Letrozole +/- Chemotherapy
for Ovarian Cancer
This phase III trial studies how well letrozole with or without paclitaxel and carboplatin works in treating patients with stage II-IV low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum. Letrozole is an enzyme inhibitor that lowers the amount of estrogen made by the body which in turn may stop the growth of tumor cells that need estrogen to grow. Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether giving letrozole alone or in combination with paclitaxel and carboplatin works better in treating patients with low-grade serous carcinoma of the ovary, fallopian tube, or peritoneum compared to paclitaxel and carboplatin without letrozole.
Recruiting2 awards Phase 318 criteria
More about Theresa Werner, MD
Clinical Trial Related2 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Theresa Werner, MD has experience with
- Carboplatin
- Letrozole
- Paclitaxel
- Upifitamab Rilsodotin
- Abemaciclib
- Upifitamab Rilsodotin
Breakdown of trials Theresa Werner, MD has run
Ovarian Cancer
Adenocarcinoma
Cancer
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Theresa Werner, MD specialize in?
Theresa Werner, MD focuses on Ovarian Cancer and Adenocarcinoma. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Theresa Werner, MD currently recruiting for clinical trials?
Yes, Theresa Werner, MD is currently recruiting for 5 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Theresa Werner, MD has studied deeply?
Yes, Theresa Werner, MD has studied treatments such as Carboplatin, Letrozole, Paclitaxel.
What is the best way to schedule an appointment with Theresa Werner, MD?
Apply for one of the trials that Theresa Werner, MD is conducting.
What is the office address of Theresa Werner, MD?
The office of Theresa Werner, MD is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.